Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Fensterer, Heiko ^a,i   Radlwimmer, Bernhard ^b   Sträter, Jörn ^a   Buchholz, Malte ^a,i   Aust, Daniela E ^c   Julié, Catherine ^e   Radvanyi, François ^f   Nordlinger, Bernard ^e   Belluco, Claudio ^g   Van Cutsem, Eric ^h   Köhne, Claus Henning ^j   Kestler, Hans A ^a   Schwaenen, Carsten ^a   Nessling, Michelle ^b   Lutz, Manfred P ^d   Lichter, Peter ^b   Gress, Thomas M ^a,i  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Caritasklinik ^*  (Germany)

^e HÔPITAL AMBROISE PARÉ   (France)

^f INSTITUT CURIE   (France)

^g National Cancer Institute   (Italy)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

^j KLINIKUM OLDENBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; FIXATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME LOSS; CHROMOSOME MAP; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; ONCOGENE; PILOT STUDY; PROGNOSIS; TISSUE FIXATION; TISSUE SECTION; VALIDITY; CLINICAL TRIAL; COLORECTAL TUMOR; DISSECTION; GENE EXPRESSION PROFILING; GENETICS; LABORATORY DIAGNOSIS; MULTICENTER STUDY; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; RISK ASSESSMENT; VALIDATION STUDY;

CLINICAL TRIALS; COLORECTAL NEOPLASMS; DISSECTION; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; PARAFFIN EMBEDDING; PILOT PROJECTS; PROGNOSIS; RISK ASSESSMENT; SPECIMEN HANDLING;

EID: 34247400139     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-58     Document Type: Article

References (36)

1. Kallioniemi A Kallioniemi OP Sudar D Rutovitz D Gray JW Waldman F Pinkel D Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors Science 1992 258 818-821 10.1126/science.1359641 1359641
2. Bentz M Plesch A Stilgenbauer S Dohner H Lichter P Minimal sizes of deletions detected by comparative genomic hybridization Genes Chromosomes Cancer 1998 21 172-175 10.1002/ (SICI)1098-2264(199802)21:2<172::AID-GCC14>3.0.CO;2-T 9491330
3. Kirchhoff M Gerdes T Maahr J Rose H Bentz M Dohner H Lundsteen C Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals Genes Chromosomes Cancer 1999 25 410-413 10.1002/ (SICI)1098-2264(199908)25:4<410::AID-GCC17>3.0.CO;2-J 10398439
4. Solinas-Toldo S Lampel S Stilgenbauer S Nickolenko J Benner A Dohner H Cremer T Lichter P Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances Genes Chromosomes Cancer 1997 20 399-407 10.1002/ (SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I 9408757
5. Pinkel D Segraves R Sudar D Clark S Poole I Kowbel D Collins C Kuo WL Chen C Zhai Y Dairkee SH Ljung BM Gray JW Albertson DG High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat Genet 1998 20 207-211 10.1038/2524 9771718
6. Mendrzyk F Radlwimmer B Joos S Kokocinski F Benner A Stange DE Neben K Fiegler H Carter N Reifenberger G Korshunov A Lichter P Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma J Clin Oncol 2005 23 8853-8862 10.1200/JCO.2005.02.8589 16314645
7. Van Cutsem E Labianca R Hossfeld D Bodoky G Roth A Aranda E Nordlinger B Assadourian S Wang K Cunningham D Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/ FA (F) in stage III colon cancer patients (pts). (PETACC 3) J Clin Oncol (Meeting Abstracts) 2005 23 LBA8
8. Paris PL Albertson DG Alers JC Andaya A Carroll P Fridlyand J Jain AN Kamkar S Kowbel D Krijtenburg PJ Pinkel D Schroder FH Vissers KJ Watson VJE Wildhagen MF Collins C van Dekken H High-Resolution Analysis of Paraffin-Embedded and Formalin-Fixed Prostate Tumors Using Comparative Genomic Hybridization to Genomic Microarrays Am J Pathol 2003 162 763-770 12598311
9. Nessling M Richter K Schwaenen C Roerig P Wrobel G Wessendorf S Fritz B Bentz M Sinn HP Radlwimmer B Lichter P Candidate Genes in Breast Cancer Revealed by Microarray-Based Comparative Genomic Hybridization of Archived Tissue Cancer Res 2005 65 439-447 15695385
10. DeVries S Nyante S Korkola J Segraves R Nakao K Moore D Bae H Wilhelm M Hwang S Waldmann F Array-Based Comparative Genomic Hybridization from Formalin-Fixed, Paraffin-Embedded Breast Tumors J Mol Diagn 2005 7 65-71 15681476
11. Sambrook J Fitsch EF Maniatis T Molecular Cloning: A Laboratory Manual Cold Spring Harbor, Cold Spring Harbor Press 1989
12. Cappellen D Gil Diez dM Chopin D Thiery JP Radvanyi F Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder Oncogene 1997 14 3059-3066 10.1038/ sj.onc.1201154 9223669
13. Schwaenen C Nessling M Wessendorf S Salvi T Wrobel G Radlwimmer B Kestler HA Haslinger C Stilgenbauer S Dohner H Bentz M Lichter P Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations Proc Natl Acad Sci USA 2004 101 1039 -1044 327147 14730057 10.1073/pnas.0304717101
14. Hoang JM Cottu PH Thuille B Salmon RJ Thomas G Hamelin R BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines Cancer Res 1997 57 300-303 9000572
15. Loukola A Salovaara R Kristo P Moisio AL Kaariainen H Ahtola H Eskelinen M Harkonen N Julkunen R Kangas E Ojala S Tulikoura J Valkamo E Jarvinen H Mecklin JP de la Chapelle A Aaltonen LA Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer Am J Pathol 1999 155 1849-1853 10595914
16. Lichter P Bentz M Joos S Detection of chromosomal aberrations by means of molecular cytogenetics: Painting of chromosomes and chromosomal subregions and comparative genomic hybridization Methods Enzymol 1995 254 334-359 8531697
17. Bubendorf L Kononen J Koivisto P Schraml P Moch H Gasser TC Willi N Mihatsch MJ Sauter G Kallioniemi OP Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays Cancer Res 1999 59 803-806 10029066
18. Korn WM Yasutake T Kuo WL Warren RS Collins C Tomita M Gray J Waldmann FM Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization Genes Chromosomes Cancer 1999 25 82-90 10.1002/ (SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6 10337990
19. Nakao K Mehta KR Fridlyand J Moore DH Jain AN Lafuente A Wiencke JW Terdiman JP Waldmann FM High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization Carcinogenesis 2004 25 1345-1357 10.1093/carcin/bgh134 15001537
20. Douglas EJ Fiegler H Rowan A Halford S Bicknell DC Bodmer W Tomlinson IPM Carter NP Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas Cancer Res 2004 64 4817-4825 10.1158/0008-5472.CAN-04-0328 15256451
21. Jones AM Douglas EJ Halford SE Fiegler H Gorman PA Roylance RR Carter NP Tomlinson IPM Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma Oncogene 2004 24 118-129 10.1038/sj.onc.1208194
22. Moertel CG Fleming TR Macdonald JS Haller DG Laurie JA Tangen CM Ungerleider JS Emerson WA Tormey DC Glick JH Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report Ann Intern Med 1995 122 321-326 7847642
23. Rooney PH Boonsong A McKay JA Marsh S Stevenson DA Murray GI Curran S Haites NE Cassidy J McLeod HL Colorectal cancer genomics: Evidence for multiple genotypes which influence survival Br J Cancer 2001 85 1492-1498 10.1054/bjoc.2001.2095 11720434
24. Eppert K Scherer SW Ozcelik H Pirone R Hoodless P Kim H Tsui LC Bapat B Gallinger S Andrulis IL Thomsen GH Wrana JL Attisano L MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma Cell 1996 86 543-552 10.1016/S0092-8674(00)80128-2 8752209
25. Hahn SA Schutte M Hoque AT Moskaluk CA da Costa LT Rozenblum E Weinstein CL Fischer A Yeo CJ Hruban RH Kern SE DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 1996 271 350-353 10.1126/ science.271.5247.350 8553070
26. Woodford-Richens KL Rowan AJ Gorman P Halford S Bicknell DC Wasan HS Roylance RR Bodmer WF Tomlinson IPM SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway PNAS 2001 98 9719-9723 55519 11481457 10.1073/pnas.171321498
27. Jen J Kim H Piantadosi S Liu ZF Levitt RC Sistonen P Kinzler KW Vogelstein B Hamilton SR Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 1994 331 213-221 10.1056/ NEJM199407283310401 8015568
28. Alazzouzi H Alhopuro P Salovaara R Sammalkorpi H Jarvinen H Mecklin JP Hemminki A Schwartz S Aaltonen LA Arango D SMAD4 as a Prognostic Marker in Colorectal Cancer Clin Cancer Res 2005 11 2606-2611 10.1158/ 1078-0432.CCR-04-1458 15814640
29. Boulay JL Mild G Lowy A Reuter J Lagrange M Terracciano L Laffer U Herrmann R Rochlitz C SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer Br J Cancer 2002 87 630-634 10.1038/sj.bjc.6600511 12237773
30. Reilly JT FLT3 and its role in the pathogenesis of acute myeloid leukaemia Leuk Lymphoma 2003 44 1-7 10.1080/1042819021000040233 12691136
31. Zhang H Wu J Meng L Shou CC Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells World J Gastroenterol 2002 8 994-998 12439912
32. Wing LY Chen HM Chuang PC Wu MH Tsai SJ The Mammalian Target of Rapamycin-p70 Ribosomal S6 Kinase but Not Phosphatidylinositol 3-Kinase-Akt Signaling Is Responsible for Fibroblast Growth Factor-9-induced Cell Proliferation J Biol Chem 2005 280 19937-19947 10.1074/jbc.M411865200 15760907
33. Jin C Wang F Wu X Yu C Luo Y McKeehan WL Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors Cancer Res 2004 64 4555-4562 10.1158/0008-5472.CAN-03-3752 15231666
34. Schaefer KL Wai DH Poremba C Korsching E van Valen F Ozaki T Boecker W Dockhorn-Dworniczak B Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays Virchows Arch 2002 440 476-484 10.1007/s00428-001-0558-9 12021921
35. Todo T Kondo T Kirino T Asai A Adams EF Nakamura S Ikeda K Kurokowa T Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors Neurosurgery 1998 43 337-346 10.1097/ 00006123-199808000-00098 9696088
36. Penault-Llorca F Bertucci F Adelaide J Parc P Coulier F Jacquemier J Birnbaum D deLapeyriere O Expression of FGF and FGF receptor genes in human breast cancer Int J Cancer 1995 61 170-176 10.1002/ijc.2910610205 7705943